Tirzepatide (low dose)
Ingredient · In our Low-Dose Tirzepatide Injection
Tirzepatide, at a lower dose
Tirzepatide acts on two gut hormone pathways at once, GLP-1 and GIP, that help your body manage blood sugar and insulin. Here it's prescribed at a lower dose with metabolic health in mind.1
Photo is an illustration, not the medicine. Tirzepatide is made in a lab.
Tirzepatide is FDA-approved to improve blood sugar control in type 2 diabetes, as Mounjaro.1 Prescribing a lower dose for metabolic health in people without diabetes is off-label, which means it's a clinician's judgment call rather than an FDA-approved use. Our tirzepatide is compounded by a licensed pharmacy, and compounded versions are not FDA-approved.3
The studies below used FDA-approved products or other forms. Our compounded version hasn't been studied in trials, and results may differ.
What it is
After you eat, your gut releases two hormones, GLP-1 and GIP, that help your body release insulin when blood sugar rises. Tirzepatide activates both, and it's taken as one injection a week.1
Why it's in this product
Blood sugar and insulin can get harder to manage in midlife. The FDA-approved version of tirzepatide has been studied for blood sugar control.2 Low doses for this purpose haven't been tested in their own trials. Your clinician decides if it fits.
What the studies in people show
- Randomized trialLower blood sugar, even at the lowest studied doseIn 478 adults with type 2 diabetes, weekly FDA-approved Mounjaro (tirzepatide) lowered HbA1c (a three-month blood sugar average) by 1.87 points at 5 mg, the lowest dose studied, and by up to 2.07 points at 15 mg over 40 weeks, compared with almost no change on placebo.2
What we don't know yet
That trial was in people with type 2 diabetes, using brand-name tirzepatide at standard doses. Whether a lower dose helps metabolic health in people without diabetes hasn't been tested directly, and compounded versions haven't been compared head to head with the brand.3
Safety, in plain English
The most common side effects are nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and belly pain.1 Rarer but serious risks on the label include pancreatitis, gallbladder problems and low blood sugar when it's combined with insulin or certain diabetes pills. Tirzepatide carries a boxed warning because it caused thyroid C-cell tumors in rats, and it isn't used by people with a personal or family history of medullary thyroid cancer or MEN 2.1
It can also make birth control pills less reliable after you start and after each dose increase, so your clinician may suggest a backup method.1 A licensed clinician reviews your health history and decides whether tirzepatide is appropriate for you. Exploring it here never means you'll get a prescription.
Curious about Low-Dose Tirzepatide Injection?
Start with a free assessment. A licensed clinician reviews your health history and decides whether treatment is appropriate. No pressure, and no prescription unless it makes sense for you.
See Low-Dose Tirzepatide InjectionHow care worksSources
- U.S. National Library of Medicine, DailyMed. Mounjaro (tirzepatide) injection: prescribing information. DailyMed
- Rosenstock J, Wysham C, Frías JP, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Lancet. 2021;398:143-155. PubMed 34186022
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA
Sources checked November 8, 2026. This page is general education, not medical advice, and it doesn't mean any treatment is right for you. Photos: Unsplash (Jess Bate).